Awareness and prescribing of the Wegovy pill for weight loss surge among primary care physicians and endocrinologists ...

Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a ...

The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity ...

Lilly's Zepbound surpasses Wegovy in dollar sales, while pricing cuts and copycats pressure Novo's growth outlook.

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

Kroger said it is now stocking Eli Lilly's injection pen version of the weight-loss drug Zepbound, and will allow self-pay customers to use Lilly's savings card at its retail pharmacies. The ...

Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

A new battle between these longtime rival companies will likely go the same way as their previous battles.